Your browser doesn't support javascript.
loading
Patterns of type 2 diabetes monitoring in rural towns: How does frequency of HbA1c and lipid testing compare with existing guidelines?
Paul, Christine L; Piterman, Leon; Shaw, Jonathan E; Kirby, Catherine; Barker, Daniel; Robinson, Jennifer; Forshaw, Kristy L; Sikaris, Kenneth A; Bisquera, Alessandra; Sanson-Fisher, Robert W.
Afiliação
  • Paul CL; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
  • Piterman L; School of Medicine and Public Health, Callaghan, Australia.
  • Shaw JE; Department of General Practice, Berwick and Peninsula Campuses, Monash University, Berwick, Australia.
  • Kirby C; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Melbourne, Australia.
  • Barker D; Clinical Diabetes and Epidemiology Group, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia.
  • Robinson J; Department of General Practice, Berwick and Peninsula Campuses, Monash University, Berwick, Australia.
  • Forshaw KL; School of Medicine and Public Health, Callaghan, Australia.
  • Sikaris KA; Centre for Clinical Epidemiology and Biostatistics, University of Newcastle, Callaghan, Australia.
  • Bisquera A; School of Medicine and Public Health, Callaghan, Australia.
  • Sanson-Fisher RW; Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
Aust J Rural Health ; 24(6): 371-377, 2016 Dec.
Article em En | MEDLINE | ID: mdl-27086673
ABSTRACT

OBJECTIVE:

To indicate levels of monitoring of type 2 diabetes in rural and regional Australia by examining patterns of glycated haemoglobin (HbA1c) and blood lipid testing. DESIGN AND

SETTING:

Retrospective analysis of pathology services data from twenty regional and rural towns in eastern Australia over 24 months.

PARTICIPANTS:

Of 13 105 individuals who had either a single HbA1c result ≥7.0% (53 mmol mol-1 ); or two or more HbA1c tests within the study period. MAIN OUTCOME

MEASURES:

Frequency of testing of HbA1c and blood lipids (cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol and triglycerides) were compared with guideline recommendations.

RESULTS:

About 58.3% of patients did not have the recommended 6-monthly HbA1c tests and 30.6% did not have annual lipid testing. For those who did not receive tests at the recommended interval, the mean between-test interval was 10.5 months (95% CI = 7.5-13.5) rather than 6 months for HbA1c testing; and 15.7 (95% CI = 13.3-18.1) months rather than annually for blood lipids. For those with at least one out-of-range test result, 77% of patients failed to receive a follow-up HbA1c test and 86.5% failed to receive a follow-up blood lipid test within the recommended 3 months. Patients less than 50 years of age, living in a more remote area and with poor diabetes control were less likely to have testing at the recommended intervals (P < 0.0001).

CONCLUSIONS:

Although poor diabetes testing is not limited to rural areas, more intensive diabetes monitoring is likely to be needed for patients living in non-metropolitan areas, particularly for some subgroups.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hemoglobinas Glicadas / Fidelidade a Diretrizes / Diabetes Mellitus Tipo 2 / Lipídeos Tipo de estudo: Guideline / Observational_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hemoglobinas Glicadas / Fidelidade a Diretrizes / Diabetes Mellitus Tipo 2 / Lipídeos Tipo de estudo: Guideline / Observational_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article